David Scott Moore - 02 Oct 2025 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role: Director
Signature: /s/ Leiv Lea, as Attorney-in-Fact for David Scott Moore
Issuer symbol: CRVS
Transactions as of: 02 Oct 2025
Net transactions value: $0
Form type: 4
Filing time: 06 Oct 2025, 16:34:34 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Moore David Scott	Director	C/O CORVUS PHARMACEUTICALS, INC., 901 GATEWAY BOULEVARD, THIRD FLOOR, SOUTH SAN FRANCISCO	/s/ Leiv Lea, as Attorney-in-Fact for David Scott Moore	06 Oct 2025	0002088466

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRVS	Stock Option (Right to Buy)	Award	$0	+30,000		$0.000000	30,000	02 Oct 2025	Common Stock	30,000	$7.04	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The underlying shares subject to the option vest and become exercisable as to one-third (1/3rd) of the shares subject to the option on each annual anniversary measured from October 2, 2025, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.